trending Market Intelligence /marketintelligence/en/news-insights/trending/KeEL_LWQIjMjN_jRHFgEig2 content esgSubNav
In This List

Intellipharmaceutics to raise $4M

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Intellipharmaceutics to raise $4M

Intellipharmaceutics International Inc. agreed to sell 3,636,364 shares at $1.10 apiece in a registered direct offering with certain investors.

The shares come bundled with warrants to purchase up to an additional 1,818,182 shares at $1.25 apiece.

Intellipharmaceutics expects to raise about $4 million in gross proceeds, which will be used for general corporate purposes.

H.C. Wainwright & Co. is acting as exclusive placement agent for the offering, which is expected to close by Oct. 13.